Bruker Corporation (BRKR)
NASDAQ:BRKR
Want to see BRKR full AI Analyst Report?
BRKR Stock Chart & Stats
$40.70
-$0.59(-0.96%)
At close: 4:00 PM EST
$40.70
-$0.59(-0.96%)
Day’s Range― - ―
52-Week Range$28.53 - $64.54
Previous CloseN/A
Volume340.61K
Average Volume (3M)2.86M
Market Cap
$8.62B
Enterprise Value$10.03B
Total Cash (Recent Filing)$133.40M
Total Debt (Recent Filing)$1.67B
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Aug 05, 2026EPS Estimate
0.39Next Dividend Ex-DateN/A
Dividend Yield0.42%
Share Statistics
EPS (TTM)-0.24
Shares Outstanding152,225,620
10 Day Avg. Volume3,145,180
30 Day Avg. Volume2,855,896
Financial Highlights & Ratios
PEG Ratio6.94
Price to Book (P/B)2.91
Price to Sales (P/S)2.08
P/FCF Ratio514.48
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue2.90
Enterprise Value/Gross Profit6.37
Enterprise Value/Ebitda33.14
Forecast
1Y Price Target
$51.50Price Target Upside26.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)2.12
Revenue Forecast (FY)$3.59B
Bulls Say, Bears Say
Bulls Say
Analyst Recommendation And ValuationAnalysts maintain buy ratings while applying a reduced valuation multiple versus peers, signaling confidence in the long-term upside given the current lower valuation.
Cost Reduction ProgramA large cost-reduction program is expected to support meaningful margin and earnings improvement if execution remains on track.
Diversified Business GrowthHealthy growth in businesses outside the weak U.S. market, including lab automation and spatial biology, supports diversified revenue prospects.
Bears Say
Guidance And Execution RiskCompany guidance implies a steep ramp in revenue and margins, increasing execution risk for achieving annual targets.
Margin ShortfallA reported quarterly gross margin shortfall raises questions about near-term profitability and puts pressure on investor confidence.
Revenue Seasonality And VisibilityUnusual revenue seasonality and irregular timing make it difficult for investors to observe steady progress and increase uncertainty around growth momentum.
Bruker News
BRKR FAQ
What was Bruker Corporation’s price range in the past 12 months?
Bruker Corporation lowest stock price was $28.53 and its highest was $64.54 in the past 12 months.
What is Bruker Corporation’s market cap?
Bruker Corporation’s market cap is $8.62B.
When is Bruker Corporation’s upcoming earnings report date?
Bruker Corporation’s upcoming earnings report date is Aug 05, 2026 which is in 49 days.
How were Bruker Corporation’s earnings last quarter?
Bruker Corporation released its earnings results on May 06, 2026. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.229 by $0.081.
Is Bruker Corporation overvalued?
According to Wall Street analysts Bruker Corporation’s price is currently Undervalued.
Does Bruker Corporation pay dividends?
Bruker Corporation pays a Quarterly dividend of $0.05 which represents an annual dividend yield of 0.42%. See more information on Bruker Corporation dividends here
What is Bruker Corporation’s EPS estimate?
Bruker Corporation’s EPS estimate is 0.39.
How many shares outstanding does Bruker Corporation have?
Bruker Corporation has 152,225,620 shares outstanding.
What happened to Bruker Corporation’s price movement after its last earnings report?
Bruker Corporation reported an EPS of $0.31 in its last earnings report, beating expectations of $0.229. Following the earnings report the stock price went up 11.287%.
Which hedge fund is a major shareholder of Bruker Corporation?
Currently, no hedge funds are holding shares in BRKR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bruker Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$51.50 (26.54% Upside)
$51.50 (26.54% Upside)
Blogger Sentiment
Neutral
BRKR Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 242.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.65%
12-Months-Change
Fundamentals
Return on Equity
-0.51%
Trailing 12-Months
Asset Growth
3.33%
Trailing 12-Months
Company Description
Bruker Corporation
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
BRKR Company Deck
BRKR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a cautiously constructive picture: management beat Q1 expectations, highlighted multiple high-growth, AI-driven and idiosyncratic end-market opportunities (Semi Metrology, SciY, security detection, BEST superconductors), and is delivering cost savings above original targets while reconfirming full-year guidance. These positives are balanced against meaningful near-term organic revenue declines, China and academic funding weaknesses, margin and mix pressures, and EPS softening in Q1. On balance, the positive operational momentum (strong bookings, large multi-year orders, and expanded cost savings) and reconfirmed guidance slightly outweigh the current headwinds.View all BRKR earnings summariesBRKR Stock 12 Month Forecast
Average Price Target
$51.50
▲(26.54% Upside)
Technical Analysis
Ownership Overview
27.04% Insiders
23.00% Mutual Funds
17.75% Other Institutional Investors
14.64% Public Companies and
Individual Investors